Karen Matthews

Karen Matthews

Auto-generated profile, based on publicly available information

Karen Matthews

Centre for Liver and Digestive Disorders Royal Infirmary of Edinburgh Edinburgh UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2018 in Journal of Clinical Nursing
Verified
Journal Article
Open access
PDF file
KMKaren Matthews
Karen Matthews
AMAlastair MacGilchrist
Alastair MacGilchrist
MCMargaret Coulter‐Smith
Margaret Coulter‐Smith
JJJacklyn Jones
Jacklyn Jones
RCRoseanne Cetnarskyj
Roseanne Cetnarskyj
Aims and objectives: To determine whether a portable FibroScan®device can be an acceptable screening tool for chronic liver disease in a community alcohol support service, through recording uptake, determining apparent prevalence of undiagnosed fibrosis/cirrhosis in participants and report engagement following referral to specialist liver services of those individuals referred because of a FibroScan®reading ≥ 7.1 kilopascals (kPa).Background: Alcohol‐related liver disease, including cirrhosis, is a major cause of death in theUK. Liver disease is silent and usually presents late. Socially deprived patients with alcohol‐related liver disease are a “hard to engage” population and at higher risk of death than less deprived. A FibroScan®device is a non‐invasive tool for measuring liver stiffness. A result of ≥7.1 kPa can indicate possible chronic liver disease.Design: Prospective observational study.Method: Individuals who self‐identified as harmful drinkers were recruited. Consented individuals attended for a liver FibroScan®. Those with a reading ≥7.1 kPa were referred to a nurse‐led liver clinic for further investigations, results of which determined referral to a liver specialist in secondary care. Participants referred were monitored for compliance over a 6‐month period.Results: Seventy‐nine consented individuals participated, an uptake of 67% of those informed of the study. Of the 79 scans performed, three were unreliable leaving 76 participants. After scanning, 20/76 (26%) had a FibroScan®≥7.1 kPa requiring referral on to the nurse‐led clinic. All 20 (100%) engaged in further assessment. Of those, 12 required onward referral to specialist services. Subsequent compliance with specialist services in this sample (n = 12) was ≥90%.Conclusion: A nurse‐led FibroScan®outreach clinic encourages socially deprived drinkers to engage with liver services.Relevance to clinical practice: A 67% uptake suggests a nurse‐led FibroScan®service in a community alcohol service is acceptable. High engagement gives potential for early intervention and improved health outcomes.